share_log

Teladoc Health | 8-K: Teladoc Health Reports Second Quarter 2024 Results

Teladoc Health | 8-K: Teladoc Health Reports Second Quarter 2024 Results

Teladoc Health | 8-K:Teladoc Health 公布2024年第二季度业绩
美股SEC公告 ·  07/31 16:08

Moomoo AI 已提取核心信息

On July 31, 2024, Teladoc Health, Inc. reported its financial results for the second quarter of 2024. The company experienced a 2% decrease in revenue year-over-year, totaling $642.4 million. Notably, the quarter included a substantial net loss of $837.7 million, or $4.92 per share, largely due to a goodwill impairment charge of $790.0 million related to its BetterHelp segment. Despite the overall net loss, Teladoc Health's adjusted EBITDA rose by 24% to $89.5 million. The Integrated Care segment saw a revenue increase of 5% to $377.4 million, while the BetterHelp segment's revenue declined by 9% to $265.0 million. The company's new CEO, Chuck Divita, acknowledged the need to address performance challenges and streamline operations. Teladoc Health has withdrawn its full-year 2024 financial outlook for both its Consolidated operations and BetterHelp segment, previously provided on April 25, 2024. The earnings conference call took place on the same day as the report release.
On July 31, 2024, Teladoc Health, Inc. reported its financial results for the second quarter of 2024. The company experienced a 2% decrease in revenue year-over-year, totaling $642.4 million. Notably, the quarter included a substantial net loss of $837.7 million, or $4.92 per share, largely due to a goodwill impairment charge of $790.0 million related to its BetterHelp segment. Despite the overall net loss, Teladoc Health's adjusted EBITDA rose by 24% to $89.5 million. The Integrated Care segment saw a revenue increase of 5% to $377.4 million, while the BetterHelp segment's revenue declined by 9% to $265.0 million. The company's new CEO, Chuck Divita, acknowledged the need to address performance challenges and streamline operations. Teladoc Health has withdrawn its full-year 2024 financial outlook for both its Consolidated operations and BetterHelp segment, previously provided on April 25, 2024. The earnings conference call took place on the same day as the report release.
2024年7月31日,teladoc health公布了2024年第二季度的财务业绩。该公司的营业收入同比下降2%,总计642.4百万美元。值得注意的是,本季度出现了巨额净亏损837.7百万美元,每股4.92美元,这主要是由于其betterhelp部门的790百万美元商誉减值损失所致。尽管净亏损总体上下降了,但teladoc health的调整后EBITDA上涨了24%,达到895百万美元。综合医疗服务部门的营业收入增长了5%,达到377.4百万美元,而betterhelp部门的营业收入下降了9%,达到265百万美元。该公司的新CEO查克·迪维塔(Chuck Divita)承认需要解决绩效挑战并精简运营。teladoc health已于2024年4月25日发布了其整体经营和betterhelp部门的2024年全年财务展望,现已撤回。业绩会议在同一天举行。
2024年7月31日,teladoc health公布了2024年第二季度的财务业绩。该公司的营业收入同比下降2%,总计642.4百万美元。值得注意的是,本季度出现了巨额净亏损837.7百万美元,每股4.92美元,这主要是由于其betterhelp部门的790百万美元商誉减值损失所致。尽管净亏损总体上下降了,但teladoc health的调整后EBITDA上涨了24%,达到895百万美元。综合医疗服务部门的营业收入增长了5%,达到377.4百万美元,而betterhelp部门的营业收入下降了9%,达到265百万美元。该公司的新CEO查克·迪维塔(Chuck Divita)承认需要解决绩效挑战并精简运营。teladoc health已于2024年4月25日发布了其整体经营和betterhelp部门的2024年全年财务展望,现已撤回。业绩会议在同一天举行。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息